Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haeryoung Kim

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Acta Diabetologica|March 28, 2014
Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetesSoo Lim, Jae Hyun Bae, Eun Ju Chun, et al.
Pancreas|March 14, 2014
CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survivalSang Hyub Lee, Haeryoung Kim, Jin-Hyeok Hwang, et al.
Oncotarget|May 10, 2014
Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growthAudrey Vincent, Seung-Mo Hong, Chaoxin Hu, et al.
Cancer Gene Therapy|January 25, 2024
Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migrationJun Bum Park, Geon Ho Moon, Ara Cho, et al.
Korean Journal of Radiology|January 14, 2022
Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic CorrelationJi Hoon Park, Yoo-Seok Yoon, Seungjae Lee, et al.
Human Pathology|October 23, 2012
Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinomaHan Suk Ryu, Jin-Haeng Chung, Kyoungbun Lee, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesisRuben Raphael Plentz, Young Nyun Park, André Lechel, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosisHaeryoung Kim, Gi Hong Choi, Deuk Chae Na, et al.
Annals of Surgical Oncology|March 8, 2012
Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarraysJoo Kyung Park, Min A Kim, Ji Kon Ryu, et al.
Annals of Surgical Treatment and Research|January 24, 2022
Oncologic outcomes according to the location and status of resection margin in pancreas head cancer: role of radiation therapy in R1 resectionHee Ju Sohn, Hongbeom Kim, Sun Joo Kim, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Acta Diabetologica|March 28, 2014
Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetesSoo Lim, Jae Hyun Bae, Eun Ju Chun, et al.
Pancreas|March 14, 2014
CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survivalSang Hyub Lee, Haeryoung Kim, Jin-Hyeok Hwang, et al.
Oncotarget|May 10, 2014
Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growthAudrey Vincent, Seung-Mo Hong, Chaoxin Hu, et al.
Cancer Gene Therapy|January 25, 2024
Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migrationJun Bum Park, Geon Ho Moon, Ara Cho, et al.
Korean Journal of Radiology|January 14, 2022
Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic CorrelationJi Hoon Park, Yoo-Seok Yoon, Seungjae Lee, et al.
Human Pathology|October 23, 2012
Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinomaHan Suk Ryu, Jin-Haeng Chung, Kyoungbun Lee, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesisRuben Raphael Plentz, Young Nyun Park, André Lechel, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosisHaeryoung Kim, Gi Hong Choi, Deuk Chae Na, et al.
Annals of Surgical Oncology|March 8, 2012
Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarraysJoo Kyung Park, Min A Kim, Ji Kon Ryu, et al.
Annals of Surgical Treatment and Research|January 24, 2022
Oncologic outcomes according to the location and status of resection margin in pancreas head cancer: role of radiation therapy in R1 resectionHee Ju Sohn, Hongbeom Kim, Sun Joo Kim, et al.
Pageof 21